Food & medicine homology.
Cure8 research brief
Why This Matters
Researchers identified potential anti‑inflammatory mechanisms in a multi‑component herbal formula relevant to IBD pathways (NF‑κB, IL‑17) and showed in vitro reduction of pro‑inflammatory cytokines, which could guide future preclinical or clinical research.
Who Should Pay Attention
Researchers; clinicians interested in natural‑product research; patients curious about preclinical IBD studies
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This paper reports laboratory and computational work testing a multi‑component herbal formula (Jiang‑Huang‑Qing‑Yan‑Yin, JHQYY) for anti‑inflammatory and antioxidant activity relevant to IBD.
The authors used network pharmacology and molecular docking to identify candidate active ingredients (e.g., tea polyphenols, vitamin C/E, caffeine) and targets (IL‑6, TNF, IL‑1β, ALB), and then performed in vitro cellular assays showing reduced pro‑inflammatory cytokine expression and antioxidant activity in macrophage models.
The study is preclinical: findings come from computational analyses, molecular docking, chemical antioxidant assays, and cultured RAW264.7 macrophages exposed to LPS. The results support potential anti‑inflammatory effects of components of JHQYY but do not provide evidence that the formula is safe or effective in people with IBD.
If you have IBD or are considering herbal products, discuss them with your clinical team before use; this report does not substitute for clinical trials or safety data.
Keep In Mind
Findings are from network pharmacology, molecular docking, antioxidant assays, and cultured macrophage experiments (in vitro). This does not demonstrate human safety or efficacy.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationFood & medicine homology.
AuthorsMeng-Ru Liu, Yi-Ning Feng, Tao Sun +5 more
InstitutionYangzhou University
Study typeArticle
Indexed viaOpenAlex
Source typeResearch paper
PublishedAug 31, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Anti-Inflammatory Components of Artemisia scoparia Alleviate Ulcerative Colitis: An Integrated Study Combining UPLC-Q-Exactive Orbitrap MS/MS, Network Pharmacology, Molecular Docking, and In Vivo/In Vitro Validation
The study identifies specific anti-inflammatory compounds in Artemisia scoparia and shows they reduce inflammation in cell and mouse models of ulcerative colitis, suggesting potential new leads for drug or...
Unraveling Effects and Pharmacological Mechanisms of Phellodendrine on Inflammatory Bowel Disease
The study identifies a natural compound that reduced inflammation and improved multiple aspects of intestinal barrier function in a zebrafish IBD model, suggesting a new candidate for preclinical drug discovery relevant...
Changyanqing decoction ameliorates ulcerative colitis via PI3K-Akt pathway: Insights from network pharmacology and in-vitro validation.
Patients and clinicians often ask whether herbal formulas or plant compounds can help IBD. This preclinical study identifies quercetin and the PI3K–Akt pathway as potential mechanisms, which may guide future research...